Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages

Fitoterapia

Volumn 112, Issue , 2016, Pages 104-115

  Rajan, Thangavelu Soundara ^a   Giacoppo, Sabrina ^a   Iori, Renato ^b   De Nicola, Gina Rosalinda ^b   Grassi, Gianpaolo ^c   Pollastro, Federica ^d   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^c Research Centre for Industrial Crops (CRA CIN)   (Italy)

^d UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Anti inflammation; Cannabidiol; Combination therapy; LPS; Macrophages; Moringin

Indexed keywords

3 NITROTYROSINE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CANNABIDIOL; CASPASE 3; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; ISOTHIOCYANIC ACID; LIPOPOLYSACCHARIDE; MORINGIN; PROTEIN BAX; PROTEIN BCL 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; CYTOKINE; ISOTHIOCYANIC ACID DERIVATIVE; NOS2 PROTEIN, MOUSE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; IMMUNOCYTOCHEMISTRY; IMMUNOLOCALIZATION; MACROPHAGE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; UPREGULATION; WESTERN BLOTTING; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; MORINGA; RAW 264.7 CELL LINE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; APOPTOSIS REGULATORY PROTEINS; CANNABIDIOL; CYTOKINES; ISOTHIOCYANATES; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MORINGA; NITRIC OXIDE SYNTHASE TYPE II; RAW 264.7 CELLS;

EID: 84973140815     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.05.008     Document Type: Article

References (31)

1. J.A. Rankin Biological mediators of acute inflammation AACN Clin. Issues 15 2004 3 17
2. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
3. A. Ariel, I. Maridonneau-Parini, P. Rovere-Querini, J.S. Levine, and H. Muhl Macrophages in inflammation and its resolution Front. Immunol. 3 2012 324
4. R. Gautam, and S.M. Jachak Recent developments in anti-inflammatory natural products Med. Res. Rev. 29 2009 767 820
5. E.A. Abourashed Bioavailability of plant-derived antioxidants Antioxidants (Basel) 2 2013 309 325
6. G. Appendino, G. Chianese, and O. Taglialatela-Scafati Cannabinoids: occurrence and medicinal chemistry Curr. Med. Chem. 18 2011 1085 1099
7. R.G. Pertwee The pharmacology of cannabinoid receptors and their ligands: an overview Int. J. Obes. 30 2006 S13 S18
8. K. Hayakawa, K. Mishima, and M. Fujiwara Therapeutic potential of non-psychotropic cannabidiol in ischemic stroke Pharmaceuticals (Basel) 3 2010 2197 2212
9. S. Ben-Shabat, L.O. Hanus, G. Katzavian, and R. Gallily New cannabidiol derivatives: synthesis, binding to cannabinoid receptor, and evaluation of their antiinflammatory activity J. Med. Chem. 49 2006 1113 1117
10. B.A. Halkier, and J. Gershenzon Biology and biochemistry of glucosinolates Annu. Rev. Plant Biol. 57 2006 303 333
11. L. Valgimigli, and R. Iori Antioxidant and pro-oxidant capacities of ITCs Environ. Mol. Mutagen. 50 2009 222 237
12. S. Giacoppo, M. Galuppo, S. Montaut, R. Iori, P. Rollin, P. Bramanti, and E. Mazzon An overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseases Fitoterapia 106 2015 12 21
13. B. Padayachee, and H. Baijnath An overview of the medicinal importance of Moringaceae J. Med. Plant Res. 6 2012 5831 5839
14. S. Giacoppo, M. Galuppo, G.R. De Nicola, R. Iori, P. Bramanti, and E. Mazzon 4(alpha-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injury Bioorg. Med. Chem. 23 2015 80 88
15. T.S. Rajan, G.R. De Nicola, R. Iori, P. Rollin, P. Bramanti, and E. Mazzon Anticancer activity of glucomoringin isothiocyanate in human malignant astrocytoma cells Fitoterapia 110 2016 1 7
16. O. Taglialatela-Scafati, A. Pagani, F. Scala, L. De Petrocellis, V. DiMarzo, G. Grassi, and G. Appendino Cannabimovone, a cannabinoid with a rearranged Terpenoid skeleton from hemp Eur. J. Org. Chem. 2010 2010 2067 2072
17. D. Brunelli, M. Tavecchio, C. Falcioni, R. Frapolli, E. Erba, R. Iori, P. Rollin, and et al. The isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivo Biochem. Pharmacol. 79 2010 1141 1148
18. C. Muller, J. van Loon, S. Ruschioni, G.R. De Nicola, C.E. Olsen, and R. Iori Agerbirk N, taste detection of the non-volatile isothiocyanate moringin results in deterrence to glucosinolate-adapted insect larvae Phytochemistry 118 2015 139 148
19. EEC Regulation 1864/90, Enclosure VIII 1990
20. A. Pessina, R.M. Thomas, S. Palmieri, and P.L. Luisi An improved method for the purification of myrosinase and its physicochemical characterization Arch. Biochem. Biophys. 280 1990 383 389
21. R. Iori, P. Rollin, H. Streicher, J. Thiem, and S. Palmieri The myrosinase-glucosinolate interaction mechanism studied using some synthetic competitive inhibitors FEBS Lett. 385 1996 87 90
22. M. Galuppo, G.R. Nicola, R. Iori, P. Dell'utri, P. Bramanti, and E. Mazzon Antibacterial activity of glucomoringin bioactivated with myrosinase against two important pathogens affecting the health of long-term patients in hospitals Molecules 18 2013 14340 14348
23. E. Kozela, A. Juknat, N. Kaushansky, N. Rimmerman, A. Ben-Nun, and Z. Vogel Cannabinoids decrease the th17 inflammatory autoimmune phenotype J. NeuroImmune Pharmacol. 8 2013 1265 1276
24. L. Weiss, M. Zeira, S. Reich, S. Slavin, I. Raz, R. Mechoulam, and R. Gallily Cannabidiol arrests onset of autoimmune diabetes in NOD mice Neuropharmacology 54 2008 244 249
25. A. Ribeiro, V. Ferraz-de-Paula, M.L. Pinheiro, L.B. Vitoretti, D.P. Mariano-Souza, W.M. Quinteiro-Filho, A.T. Akamine, and et al. Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor Eur. J. Pharmacol. 678 2012 78 85
26. K. Takeda, and S. Akira Toll-like receptors Curr. Protoc. Immunol. 109 2015 (14 2 1- 2 0)
27. T. Kawai, and S. Akira Signaling to NF-kappaB by toll-like receptors Trends Mol. Med. 13 2007 460 469
28. O. Sharif, V.N. Bolshakov, S. Raines, P. Newham, and N.D. Perkins Transcriptional profiling of the LPS induced NF-kappaB response in macrophages BMC Immunol. 8 2007 1
29. A.Z. Karabay, F. Aktan, A. Sunguroglu, and Z. Buyukbingol Methylsulfonylmethane modulates apoptosis of LPS/IFN-gamma-activated RAW 264.7 macrophage-like cells by targeting p53, Bax, Bcl-2, cytochrome c and PARP proteins Immunopharmacol. Immunotoxicol. 36 2014 379 389
30. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65
31. V.L. Hegde, P.S. Nagarkatti, and M. Nagarkatti Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol PLoS One 6 2011 e18281